Minimizing contrast medium doses to diagnose pulmonary embolism with 80-kvp multidetector computed tomography in azotemic patients

Acta Radiologica

Volumn 50, Issue 2, 2009, Pages 181-193

  Holmquist, F ^a   Hansson, K ^b   Pasquariello, F ^b   Bjork J ^a   Nyman, U ^b  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b LUND UNIVERSITY   (Sweden)

Author keywords

Computed tomography; Contrast material; Contrast medium induced nephropathy; Nephrotoxicity; Pulmonary embolism

Indexed keywords

ANTHROPOMETRY; COLOR; COMPUTERIZED TOMOGRAPHY; DIAGNOSTIC RADIOGRAPHY; IODINE; MAGNETIC RESONANCE IMAGING; RISK PERCEPTION;

COMPUTED TOMOGRAPHY; CONTRAST MATERIAL; CONTRAST MEDIUM-INDUCED NEPHROPATHY; NEPHROTOXICITY; PULMONARY EMBOLISM;

CONTRAST MEDIA;

CONTRAST MEDIUM; IODIXANOL; IODOBENZOIC ACID DERIVATIVE;

ACUTE DISEASE; ADULT; AGED; ARTICLE; COMPUTER ASSISTED DIAGNOSIS; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HUMAN; LUNG EMBOLISM; MALE; METHODOLOGY; MIDDLE AGED; RADIOGRAPHY; RETROSPECTIVE STUDY; STATISTICAL MODEL; UREMIA;

ACUTE DISEASE; ADULT; AGED; AGED, 80 AND OVER; AZOTEMIA; CONTRAST MEDIA; FEMALE; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; PULMONARY EMBOLISM; RADIOGRAPHIC IMAGE INTERPRETATION, COMPUTER-ASSISTED; RETROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED; TRIIODOBENZOIC ACIDS;

EID: 61449268221     PISSN: 02841851     EISSN: 16000455     Source Type: Journal    
DOI: 10.1080/02841850802657269     Document Type: Article

References (45)

1. Remy-Jardin M, Pistolesi M, Goodman LR, Gefter WB, Gottschalk A, Mayo JR, et al. Management of suspected acute pulmonary embolism in the era of CT angiography: a statement from the Fleischner Society. Radiology 2007;245:315-29.
2. Gleeson TG, Bulugahapitiya S. Contrast-induced nephropathy. Am J Roentgenol 2004;183:1673-89.
3. Nyman U, Almen T, Aspelin P, Hellström M, Kristiansson M, Sterner G. Contrast-medium-induced nephropathy correlated to the ratio between dose in gram iodine and estimated GFR in m1/min. Acta Radiol 2005; 46:830-42.
4. Barrett BJ, Katzberg RW, Thomsen HS, Chen N, Sahani D, Soulez G, et al. Contrast-induced nephropathy in patients with chronic kidney disease undergoing computed tomography: a double-blind comparison of iodixanol and iopamidol. Invest Radiol 2006;41:815-21.
5. Becker CR, Reiser MF. Use of iso-osmolar nonionic dimeric contrast media in multidetector row computed tomography angiography for patients with renal impairment. Invest Radiol 2005;40:672-5.
6. Thomsen HS, Morcos SK, Erley CM, Grazioli L, Bonomo L, Ni Z, et al. The ACTIVE Trial: comparison on the effects on renal function of iomeprol-400 and iodixanol-320 in patients with chronic kidney disease undergoing abdominal computed tomography. Invest Radiol 2008;43:170-8.
7. Medicines and Healthcare Products Regulatory Agency, United Kingdom. Nephrogenic systemic fibrosis (NSF) with gadolinium-containing MRI contrast agents. 2007. Available at URL: http://www.mhra.gov.uk/Safetyinf ormation/Safetywarningsalertsandrecalls/Safetywarningsandmessagesformedicines/ CON2030229 (published February 7, 2007; accessed July 7, 2008).
8. Mehran R, Nikolsky E. Contrast-induced nephropathy: definition, epidemiology, and patients at risk. Kidney Int Suppl 2006;69:S11-5.
9. Johnson PT, Naidich D, Fishman EK. MDCT for suspected pulmonary embolism: multi-institutional survey of 16-MDCT data acquisition protocols. Emerg Radiol 2007;13:243-9.
10. Boone JM, Geraghty EM, Seibert JA, Wootton-Gorges SL. Dose reduction in pediatric CT: a rational approach. Radiology 2003;228:352-60.
11. Huda W, Scalzetti EM, Levin G. Technique factors and image quality as functions of patient weight at abdominal CT. Radiology 2000;217:430-5.
12. Sigal-Cinqualbre AB, Hennequin R, Abada HT, Chen X, Paul JF. Low-kilovoltage multi-detector row chest CT in adults: feasibility and effect on image quality and iodine dose. Radiology 2004;231:169-74.
13. Holmquist F, Nyman U. Eighty-peak kilovoltage 16-channel multidetector computed tomography and reduced contrast-medium doses tailored to body weight to diagnose pulmonary embolism in azotaemic patients. Eur Radiol 2006;16:1165-76.
14. Dorio PJ, Lee FT Jr, Henseler KP, Pilot M, Pozniak MA, Winter TC 3rd, et al. Using a saline chaser to decrease contrast media in abdominal CT. Am J Roentgenol 2003;180:929-34.
15. Nyman U, Ahl TL, Kristiansson M, Nilsson L, Wettemark S. Patient-circumference-adapted dose regulation in body computed tomography. A practical and flexible formula. Acta Radiol 2005;46:396-406.
16. Nagel HD, Galanski M, Hidajar N, Maier W, Schmidt T. Radiation exposure in computed tomography. Fundamentals, influencing parameters, dose assessment, optimization, scanner data, terminology. Hamburg: CTB Publications; 2002.
17. Heart Failure Society of America. The stages of heart failure - NYHA classification. 2002. Available at URL: http://www.abouthf.org/questions-stages. htm (accessed July 7, 2008).
18. Global Initiative for Chronic Obstructive Luna Disease. Stages of COPD. 2003. Available at URL: http://www.patienthealthinternational.com/article/ 501995.aspx (accessed July 7, 2008).
19. Bae KT, Mody GN, Balfe DM, Bhalla S, Gierada DS, Gutierrez FR, et al. CT depiction of pulmonary emboli: display window settings. Radiology 2005;236:677-84.
20. Heyer CM, Mohr PS, Lemburg SP, Peters SA, Nicolas V. Image quality and radiation exposure at pulmonary CT angiography with 100-or 120-kVp protocol: prospective randomized study. Radiology 2007;245:577-83.
21. Bae KT, Tao C, Gurel S, Hong C, Zhu F, Gebke TA, et al. Effect of patient weight and scanning duration on contrast enhancement during pulmonary multidetector CT angiography. Radiology 2007;242:582-9.
22. Kormano M, Partanen K, Soimakallio S, Kivimaki T. Dynamic contrast enhancement of the upper abdomen: effect of contrast medium and body weight. Invest Radiol 1983;18:364-7.
23. Bae KT, Heiken JP. Scan and contrast administration principles of MDCT. Eur Radiol 2005; 15(15 Suppl 5): E46-59.
24. Awai K, Hiraishi K, Hori S. Effect of contrast material injection duration and rate on aortic peak time and peak enhancement at dynamic CT involving injection protocol with dose tailored to patient weight. Radiology 2004; 230:142-50.
25. Morgan DJ, Bray KM. Lean body mass as a predictor of drug dosage. Implications for drug therapy. Clin Pharmacokinet 1994;26:292-307.
26. Bae KT, Heiken JP, Brink JA. Aortic and hepatic contrast medium enhancement at CT. Part II. Effect of reduced cardiac output in a porcine model. Radiology 1998;207:657-62.
27. Sarnak MJ, Levey AS, Schoolwerth AC, Coresh J, Culleton B, Hamm LL, et al. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation 2003;108:2154-69.
28. Mehran R, Aymong ED, Nikolsky E, Lasic Z, Iakovou I, Fahy M, et al. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol 2004;44:1393-9.
29. Schmidt C, Theilmeier G, Van Aken H, Korsmeier P, Wirtz SP, Berendes E, et al. Comparison of electrical velocimetry and transoesophageal Doppler echocardiography for measuring stroke volume and cardiac output. Br J Anaesth 2005;95:603-10.
30. Jones SE, Wittram C. The indeterminate CT pulmonary angiogram: imaging characteristics and patient clinical outcome. Radiology 2005;237:329-37.
31. Patel S, Kazerooni EA. Helical CT for the evaluation of acute pulmonary embolism. Am J Roentgenol 2005; 185: 135-49.
32. van Belle A, Buller HR, Huisman MV, Huisman PM, Kaasjager K, Kamphuisen PW, et al. Effectiveness of managing suspected pulmonary embolism using an algorithm combining clinical probability, D-dimer testing, and computed tomography. JAMA 2006;295:172-9.
33. Loud PA, Katz DS, Klippenstein DL, Shah RD, Grossman ZD. Combined CT venography and pulmonary angiography in suspected thromboembolic disease: diagnostic accuracy for deep venous evaluation. Am J Roentgenol 2000; 174:61-5.
34. Kalra M, Brady T. Care Dose4D. New technique for radiation dose reduction. Somatom Sessions 2006;19:28-31. Available at URL: http://health.siemens.com/ct-applications/customer-nagazine/somatom-sessions/ (accessed July 7, 2008).
35. Tsapaki V, Aldrich JE, Sharma R, Staniszewska MA, Krisanachinda A, Rehani M, et al. Dose reduction in CT while maintaining diagnostic confidence: diagnostic reference levels at routine head, chest, and abdominal CT-IAEA-coordinated research project. Radiology 2006;240:828-34.
36. Thomas KE, Wang B. Age-specific effective doses for pediatric MSCT examinations at a large children's hospital using DLP conversion coefficients: a simple estimation method. Pediatr Radiol 2008;38:645-56.
37. Abada HT, Larchez C, Daoud B, Sigal-Cinqualbre A, Paul JF. MDCT of the coronary arteries: feasibility of low-dose CT with ECG-pulsed tube current modulation to reduce radiation dose. Am J Roentgenol 2006; 186: S387-90.
38. Huda W, Ogden KM, Khorasani MR. Converting doselength product to effective dose at CT. Radiology 2008; 248:995-1003.
39. Hu KT, Matayoshi A, Stevenson FT. Calculation of the estimated creatinine clearance in avoiding drug dosing errors in the older patient. Am J Med Sci 2001;322: 133-6.
40. Sherwin PF, Cambron R, Johnson JA, Pierro JA. Contrast dose-to-creatinine clearance ratio as a potential indicator of risk for radiocontrast-induced nephropathy: correlation of D/CrCL with area under the contrast concentration-time curve using iodixanol. Invest Radiol 2005;40:598-603.
41. Laskey WK, Jenkins C, Selzer F, Marroquin OC, Wilensky RL, Glaser R, et al. Volume-to-creatinine clearance ratio: a pharmacokinetically based risk factor for prediction of early creatinine increase after percutaneous coronary intervention. J Am Coll Cardiol 2007; 50:584-90.
42. Nyman U, Björk J, Aspelin P, Marenzi G. Contrast medium dose-to-GFR ratio: a measure of systemic exposure to predict contrast-induced nephropathy after percutaneous coronary intervention. Acta Radiol 2008; 49:658-67.
43. Gottsäter A, Berg A, Centergård J, Frennby B, Nirhov N, Nyman U. Clinically suspected pulmonary embolism: is it safe to withhold anticoagulation after a negative spiral CT? Eur Radiol 2001;11:65-72.
44. van Strijen MJ, Bloem JL, de Monye W, Kieft GJ, Pattynama PM, van den Berg-Huijsmans A, et al. Helical computed tomography and alternative diagnosis in patients with excluded pulmonary embolism. J Thromb Haemost 2005;3:2449-56.
45. Bruce D, Loud PA, Klippenstein DL, Grossman ZD, Katz DS. Combined CT venography and pulmonary angiography: how much venous enhancement is routinely obtained? Am J Roentgenol 2001;176:1281-5.